IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,379,096 | +113.1% | 192,214 | +5.3% | 0.00% | +100.0% |
Q2 2023 | $3,463,278 | +32.1% | 182,566 | +8.0% | 0.00% | 0.0% |
Q1 2023 | $2,622,338 | -11.8% | 169,074 | +0.9% | 0.00% | 0.0% |
Q4 2022 | $2,973,303 | +256.1% | 167,510 | +11.9% | 0.00% | – |
Q3 2022 | $835,000 | +51.3% | 149,674 | +5.8% | 0.00% | – |
Q2 2022 | $552,000 | -31.8% | 141,433 | -3.7% | 0.00% | – |
Q1 2022 | $809,000 | -34.9% | 146,799 | +0.6% | 0.00% | – |
Q4 2021 | $1,243,000 | +1.8% | 145,866 | +3.8% | 0.00% | – |
Q3 2021 | $1,221,000 | -6.0% | 140,473 | +14.3% | 0.00% | – |
Q2 2021 | $1,299,000 | -45.6% | 122,868 | -17.5% | 0.00% | – |
Q1 2021 | $2,389,000 | -69.0% | 148,950 | -10.9% | 0.00% | -100.0% |
Q4 2020 | $7,718,000 | +42.0% | 167,111 | +8.2% | 0.00% | +100.0% |
Q3 2020 | $5,434,000 | +197.1% | 154,446 | +105.6% | 0.00% | – |
Q2 2020 | $1,829,000 | – | 75,104 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |